Literature DB >> 22572838

Early versus delayed cyclosporine treatment in cardiac recovery and intestinal injury during resuscitation of asphyxiated newborn piglets.

Richdeep S Gill1, Tze-Fun Lee, Consolato Sergi, David L Bigam, Po-Yin Cheung.   

Abstract

PURPOSE: We previously demonstrated that treating asphyxiated newborn piglets with cyclosporine immediately following resuscitation can improve cardiac and intestinal recovery. However, immediate treatment may not be feasible for a large portion of neonates delivered in peripheral or rural hospitals. Therefore, our objective was to determine if delayed cyclosporine treatment remained effective in treating neonatal asphyxia. We hypothesized that early and delayed cyclosporine treatment would improve cardiac and intestinal recovery during resuscitation of asphyxiated newborn piglets.
METHODS: Thirty piglets (1-4 days old) were instrumented for continuous monitoring of cardiac output and mesenteric hemodynamics. After stabilization, normocapnic alveolar hypoxia (10-15 % oxygen) was instituted for 2 h followed by reoxygenation with 100 % oxygen for 0.5 h, then 21 % for 5.5 h. Piglets were block-randomized to receive either intravenous bolus of cyclosporine A (10 mg/kg) or normal saline (control) at 5 or 120 min of reoxygenation (early or delayed, respectively; n = 8/group). Myocardial and intestinal lactate concentrations as well as histological examinations were determined.
RESULTS: Hypoxic piglets had cardiogenic shock (cardiac output 52 ± 1 % of baseline, mean arterial pressure 32 ± 1 mmHg) and acidosis (pH 6.98 ± 0.1). Although both cyclosporine treatments improved cardiac output (p < 0.05 vs. controls), only early cyclosporine treatment improved stroke volume and systemic oxygen delivery (p < 0.05 vs. controls). Left ventricle and intestinal lactate were lowered in both cyclosporine-treated groups (p < 0.05 vs. controls). Early, but not delayed, cyclosporine treatment also attenuated intestinal injury (p < 0.05 vs. controls).
CONCLUSION: This study demonstrates that treating asphyxiated newborn piglets with cyclosporine within 2 h of resuscitation is effective with superior cardioprotection and intestinal injury attenuation with early treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22572838     DOI: 10.1007/s00134-012-2577-1

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  25 in total

1.  No cry at birth: global estimates of intrapartum stillbirths and intrapartum-related neonatal deaths.

Authors:  Joy Lawn; Kenji Shibuya; Claudia Stein
Journal:  Bull World Health Organ       Date:  2005-06-17       Impact factor: 9.408

2.  Cyclosporine treatment improves cardiac function and systemic hemodynamics during resuscitation in a newborn piglet model of asphyxia: a dose-response study.

Authors:  Richdeep S Gill; Namdar Manouchehri; Jiang-Qin Liu; Tze-Fun Lee; Woo Jung Cho; Aducio Thiesen; Thomas Churchill; David Bigam; Po-Yin Cheung
Journal:  Crit Care Med       Date:  2012-04       Impact factor: 7.598

3.  Shock: a common consequence of neonatal asphyxia.

Authors:  Tina A Leone; Neil N Finer
Journal:  J Pediatr       Date:  2011-02       Impact factor: 4.406

4.  Cardiac function, myocardial glutathione, and matrix metalloproteinase-2 levels in hypoxic newborn pigs reoxygenated by 21%, 50%, or 100% oxygen.

Authors:  Erika Haase; David L Bigam; Quentin B Nakonechny; David Rayner; Gregory Korbutt; Po-Yin Cheung
Journal:  Shock       Date:  2005-04       Impact factor: 3.454

5.  Enterocyte viability and mitochondrial function after graded intestinal ischemia and reperfusion in rats.

Authors:  M Madesh; L Bhaskar; K A Balasubramanian
Journal:  Mol Cell Biochem       Date:  1997-02       Impact factor: 3.396

6.  Postconditioning inhibits mitochondrial permeability transition.

Authors:  Laurent Argaud; Odile Gateau-Roesch; Olivier Raisky; Joseph Loufouat; Dominique Robert; Michel Ovize
Journal:  Circulation       Date:  2005-01-10       Impact factor: 29.690

7.  Evidence of oxidative stress in full-term healthy infants.

Authors:  James K Friel; Russ W Friesen; Scott V Harding; L Jackson Roberts
Journal:  Pediatr Res       Date:  2004-10-06       Impact factor: 3.756

8.  Early experimental myocardial infarction. Evaluation of histologic criteria and comparison with biochemical and electrocardiographic measurements.

Authors:  A G Rose; L H Opie; O L Bricknell
Journal:  Arch Pathol Lab Med       Date:  1976-10       Impact factor: 5.534

9.  The hemodynamic effects of dobutamine during reoxygenation after hypoxia: a dose-response study in newborn pigs.

Authors:  Zakariya Al-Salam; Scott Johnson; Sameh Abozaid; David Bigam; Po-Yin Cheung
Journal:  Shock       Date:  2007-09       Impact factor: 3.454

Review 10.  Mitochondrial permeability transition pore opening during myocardial reperfusion--a target for cardioprotection.

Authors:  Andrew P Halestrap; Samantha J Clarke; Sabzali A Javadov
Journal:  Cardiovasc Res       Date:  2004-02-15       Impact factor: 10.787

View more
  3 in total

Review 1.  Novelties in pharmacological management of cardiopulmonary resuscitation.

Authors:  Jason A Bartos; Demetris Yannopoulos
Journal:  Curr Opin Crit Care       Date:  2013-10       Impact factor: 3.687

2.  Brain caspase-3 and intestinal FABP responses in preterm and term rats submitted to birth asphyxia.

Authors:  R L Figueira; F L Gonçalves; A L Simões; C A Bernardino; L S Lopes; O Castro E Silva; L Sbragia
Journal:  Braz J Med Biol Res       Date:  2016-06-23       Impact factor: 2.590

3.  Year in review in Intensive Care Medicine 2012: I. Neurology and neurointensive care, epidemiology and nephrology, biomarkers and inflammation, nutrition, experimentals.

Authors:  Massimo Antonelli; Marc Bonten; Maurizio Cecconi; Jean Chastre; Giuseppe Citerio; Giorgio Conti; J Randall Curtis; Goran Hedenstierna; Michael Joannidis; Duncan Macrae; Salvatore M Maggiore; Jordi Mancebo; Alexandre Mebazaa; Jean-Charles Preiser; Patricia Rocco; Jean-François Timsit; Jan Wernerman; Haibo Zhang
Journal:  Intensive Care Med       Date:  2012-12-18       Impact factor: 17.440

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.